SCHEMBL7736110

SCHEMBL7736110

COc1cc(OC)c(C(=O)[P](=O)c2ccccc2C(=O)c2c(C)cccc2C)c(OC)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.43
KMT2A Q03164 5/20 0.39
CYP3A4 P08684 2/20 0.39
MAPT P10636 2/20 0.39
TP53 P04637 1/20 0.39
ATM Q13315 1/20 0.39
HSD17B10 Q99714 1/20 0.39
ABCG2 Q9UNQ0 3/20 0.39
KCNK3 O14649 1/20 0.38
POLB P06746 1/20 0.38
KCNK9 Q9NPC2 1/20 0.38
USP2 O75604 1/20 0.37
MAPK1 P28482 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
MAOA P21397 1/20 0.36
MAOB P27338 1/20 0.36
TXNRD1 Q16881 1/20 0.36
TXNRD3 Q86VQ6 1/20 0.36
TXNRD2 Q9NNW7 1/20 0.36
NPC1 O15118 4/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7180294 0.95 ALDH1A1 (0.43) ALDH1A1KMT2ACYP3A4MAPTTP53
SCHEMBL7178052 0.92 ABCB1 (0.40) ALDH1A1KMT2ACYP3A4MAPTTP53
SCHEMBL7177390 0.91 CA12 (0.41) ALDH1A1KMT2AMAPTATMABCG2
SCHEMBL7189932 0.91 ALDH1A1 (0.39) ALDH1A1KMT2ACYP3A4MAPTTP53
SCHEMBL7188977 0.90 MAPT (0.41) ALDH1A1KMT2ACYP3A4MAPTTP53
SCHEMBL7733699 0.89 ALDH1A1 (0.39) ALDH1A1KMT2ACYP3A4MAPTTP53
SCHEMBL7181292 0.89 ALDH1A1 (0.38) ALDH1A1KMT2ACYP3A4MAPTTP53
SCHEMBL7185356 0.87 ALDH1A1 (0.38) ALDH1A1KMT2ACYP3A4MAPTTP53
SCHEMBL7180828 0.87 ABCB1 (0.40) ALDH1A1KMT2ACYP3A4MAPTTP53
SCHEMBL7175462 0.87 KMT2A (0.45) ALDH1A1KMT2ACYP3A4MAPTTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6399805-B2 SUCH AS LITHIUM 2,6-DIMETHYLBENZOYLPHENYLPHOSPHINE, USE AS PHOTOINITIATORS IN PHOTOCURABLE COMPOSITIONS SUCH AS FOR PHOTOGRAPHIC PRODUCTION OF RELIEF IMAGES CIBA SPECIALTY CHEMICALS CORPORATION 2002-06-04 US disclosed
US-20010031898-A1 Organometallic monoacylarylphosphines CIBA SPECIALTY CHEMICALS CORP. 2001-10-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010031898-A1 Organometallic monoacylarylphosphines NAF1, DHCR24, CBR1 ALDH1A1 3984/4885KMT2A 956/4885CYP3A4 1881/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.